Global and Region Meningococcal Group B Vaccine Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Meningococcal Group B Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Meningococcal Group B Vaccinemarket, defines the market attractiveness level of Meningococcal Group B Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Meningococcal Group B Vaccine industry, describes the types of Meningococcal Group B Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Meningococcal Group B Vaccine market and the development prospects and opportunities of Meningococcal Group B Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Meningococcal Group B Vaccine market in Chapter 13.

    By Player:

    • Pfizer

    • GSK

    By Type:

    • Type 1

    • Type 2

    By End-User:

    • Public

    • Private

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Meningococcal Group B Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Meningococcal Group B Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Meningococcal Group B Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Meningococcal Group B Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Meningococcal Group B Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Meningococcal Group B Vaccine Consumption (2017-2022)

    • 7.2 United States Meningococcal Group B Vaccine Consumption (2017-2022)

    • 7.3 Europe Meningococcal Group B Vaccine Consumption (2017-2022)

    • 7.4 China Meningococcal Group B Vaccine Consumption (2017-2022)

    • 7.5 Japan Meningococcal Group B Vaccine Consumption (2017-2022)

    • 7.6 India Meningococcal Group B Vaccine Consumption (2017-2022)

    • 7.7 South Korea Meningococcal Group B Vaccine Consumption (2017-2022)

    8 Region and Country-wise Meningococcal Group B Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    9 Global Meningococcal Group B Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Meningococcal Group B Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Meningococcal Group B Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Public Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Private Consumption and Growth Rate (2017-2022)

    10 Global Meningococcal Group B Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Meningococcal Group B Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Meningococcal Group B Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Public Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Private Consumption Forecast and Growth Rate (2022-2028)

    11 Global Meningococcal Group B Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Meningococcal Group B Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Meningococcal Group B Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Meningococcal Group B Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Meningococcal Group B Vaccine Market Competitive Analysis

    • 14.1 Pfizer

      • 14.1.1 Pfizer Company Details

      • 14.1.2 Pfizer Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Meningococcal Group B Vaccine Product and Service

    • 14.2 GSK

      • 14.2.1 GSK Company Details

      • 14.2.2 GSK Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GSK Meningococcal Group B Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Meningococcal Group B Vaccine

    • Figure Meningococcal Group B Vaccine Picture

    • Table Global Meningococcal Group B Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Meningococcal Group B Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Meningococcal Group B Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure United States Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Public Consumption and Growth Rate (2017-2022)

    • Figure Global Private Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Public Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Private Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Meningococcal Group B Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Meningococcal Group B Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Meningococcal Group B Vaccine Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Meningococcal Group B Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.